Mechanosensitive Channels: Antimicrobials, Channelopathies And Nanovalves For Drug Delivery
Funder
National Health and Medical Research Council
Funding Amount
$673,953.00
Summary
Liposomal drug delivery systems (LDDS) are one of the most advanced particulate drug carriers in modern medicine. The ultimate goal of this project is to optimize a nanotechnology approach for improved control of therapeutic drug delivery for chemotherapy. The approach is using bacterial mechanosensitive channel MscL designed to act as a molecular nanovalve for localised drug release.